Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 79,127 | 220,471 | 215,456 | 140,407 | 92,852 |
| Receivables | 112,732 | 105,842 | 46,745 | 120,370 | 86,172 |
| TOTAL | $199,201 | $332,292 | $274,178 | $273,843 | $191,753 |
| Non-Current Assets | |||||
| PPE Net | 2,913 | 3,166 | 3,408 | 3,666 | 3,929 |
| Intangibles | 1,633 | 1,838 | 2,040 | 2,247 | 2,453 |
| Other Non-Current Assets | 81,381 | 97,270 | 117,275 | 116,306 | 144,811 |
| TOTAL | $85,927 | $102,274 | $122,723 | $122,219 | $151,193 |
| Total Assets | $285,128 | $434,566 | $396,901 | $396,062 | $342,946 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 199,855 | 199,680 | 199,506 | N/A |
| Accounts payable and accrued liabilities | 911 | 3,237 | 2,898 | 1,613 | 1,389 |
| Accrued Expenses | 28,658 | 29,947 | 36,388 | 38,148 | 28,584 |
| Other current liabilities | N/A | N/A | N/A | N/A | 199,332 |
| TOTAL | $32,854 | $236,307 | $242,218 | $242,503 | $232,525 |
| Non-Current Liabilities | |||||
| Long Term Debt | 385,000 | 385,000 | 385,000 | 385,000 | 385,000 |
| Other Non-Current Liabilities | 29,117 | 30,403 | 31,518 | 32,716 | 33,583 |
| TOTAL | $414,117 | $415,403 | $416,518 | $417,716 | $418,583 |
| Total Liabilities | $446,971 | $651,710 | $658,736 | $660,219 | $651,108 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 165,240 | 164,613 | 163,058 | 162,679 | 162,434 |
| Common Shares | 165 | 165 | 163 | 163 | 162 |
| Retained earnings | -1,581,654 | -1,632,945 | -1,673,718 | -1,671,442 | -1,711,522 |
| Other shareholders' equity | -324 | -795 | -1,060 | -1,714 | -2,026 |
| TOTAL | $-161,843 | $-217,144 | $-261,835 | $-264,157 | $-308,162 |
| Total Liabilities And Equity | $285,128 | $434,566 | $396,901 | $396,062 | $342,946 |